If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Forteo ® (teriparatide [rDNA origin] injection)20-mcg daily dose in a 2.4-mL prefilled delivery device
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Teriparatide should be administered as a subcutaneous injection into the thigh or abdominal wall.1
In clinical trials, teriparatide was injected subcutaneously into the patient’s thigh or abdominal wall.1
Intravenous or Intramuscular Injection
Instructions for Teriparatide Injection
Please review the Forteo® Pen User Manual for instructions on how to properly inject teriparatide.
Enclosed Prescribing Information
1. Forteo [package insert]. Indianapolis IN: Eli Lilly and Company; 2019.
Date of Last Review: November 11, 2019